Impact BioMedical (IBO) Stock Price, Quote, News & History

Impact BioMedical Inc (IBO) Stock Price, Quote, News & History

IBOAMEX

Trade with Public

$0.6704

-0.0055-0.81%

Last update: Apr 16, 8:59 AM

Key Statistics

Open

$0.64

Volume / Avg.

56.46K / 4.37M

Day Range

$0.64 - $0.66

52 Wk Range

0.36 - 1.95

Market Cap

$72.28M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

16.31%

Days to Cover

2.15

Recent Impact Biomedical Inc News

Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why

Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio Labs.

Mohd Haider

Impact BioMedical Stock Is Soaring Monday: What's Going On?

Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchange agreement with Dr. Ashleys.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.89M

Investing Cash Flow (TTM)

3.00K

Financing Cash Flow (TTM)

-109.00K

Free Cash Flow (TTM)

-1.89M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.00M

Valuation Metrics

Enterprise Value

$95.81M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

666.40

PB Ratio (TTM)

5.78

Earnings Yield % (TTM)

-56.22%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.12

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$293.00K

Key Statistics

Open

$0.64

Volume / Avg.

56.46K / 4.37M

Day Range

$0.64 - $0.66

52 Wk Range

0.36 - 1.95

Market Cap

$72.28M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

16.31%

Days to Cover

2.15

About

Sector

Health Care

Industry

Pharmaceuticals

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmissi...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Impact BioMedical (IBO) stock?

You can purchase shares of Impact BioMedical (AMEX:IBO) through any online brokerage.

View our list of the best stock brokerages

Who are Impact BioMedical (IBO) competitors?

Other companies in Impact BioMedical’s space includes: Cingulate Inc (NASDAQ:CING), Cumberland Pharmaceuticals Inc (NASDAQ:CPIX), SCYNEXIS Inc (NASDAQ:SCYX), Aardvark Therapeutics Inc (NASDAQ:AARD) and Rani Therapeutics Holdings Inc (NASDAQ:RANI).

What is the forecast, or price target, for Impact BioMedical (IBO) stock?

There is no analysis for Impact BioMedical to provide a consensus price target.

What is the current price for Impact BioMedical (IBO)?

The stock price for Impact BioMedical (AMEX: IBO) is $0.6704 last updated April 16, 2026 at 8:59 AM EDT.

Does Impact BioMedical (IBO) pay a dividend?

There are no upcoming dividends for Impact BioMedical.

When is Impact BioMedical (AMEX:IBO) reporting earnings?

Impact BioMedical does not have any upcoming earnings scheduled.

Is Impact BioMedical (IBO) going to split?

There is no upcoming split for Impact BioMedical.

What sector and industry does Impact BioMedical (IBO) operate in?

Impact BioMedical is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

People Also Watch

Cumberland Pharmaceuticals Inc

Aardvark Therapeutics Inc

NASDAQ:AARD

$4.95

-2.56%

Rani Therapeutics Holdings Inc

NASDAQ:RANI

$0.88

-8.46%

Incannex Healthcare Inc

Telomir Pharmaceuticals Inc

NASDAQ:TELO

$1.32

-1.57%

Key Statistics

Open

$0.64

Volume / Avg.

56.46K / 4.37M

Day Range

$0.64 - $0.66

52 Wk Range

0.36 - 1.95

Market Cap

$72.28M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

16.31%

Days to Cover

2.15

Recent Impact Biomedical Inc News

Impact Biomedical (IBO) Stock Jumps Over 86% After Hours — Here's Why

Impact Biomedical shares jumped 86% after hours following amended merger terms with Dr Ashleys Bio Labs.

Mohd Haider

Impact BioMedical Stock Is Soaring Monday: What's Going On?

Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchange agreement with Dr. Ashleys.

Dylan Berman

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-1.89M

Investing Cash Flow (TTM)

3.00K

Financing Cash Flow (TTM)

-109.00K

Free Cash Flow (TTM)

-1.89M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.00M

Valuation Metrics

Enterprise Value

$95.81M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

666.40

PB Ratio (TTM)

5.78

Earnings Yield % (TTM)

-56.22%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.12

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$293.00K

Key Statistics

Open

$0.64

Volume / Avg.

56.46K / 4.37M

Day Range

$0.64 - $0.66

52 Wk Range

0.36 - 1.95

Market Cap

$72.28M

P/E Ratio

Dividend Yield

Exchange

AMEX

RSI

Short Interest

16.31%

Days to Cover

2.15

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry